The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
On the Proper Use of the Crossover Design in Clinical Trials
Open accessAbstract
BACKGROUND: Many clinical trials have a crossover design. Certain considerations that are relevant to the crossover design, but play no role in standard parallel-group trials, must receive adequate attention in trial planning and data analysis for the results to be of scientific value. METHODS: The authors present the basic statistical methods required for the analysis of crossover trials, referring to standard statistical texts. RESULTS: In the simplest and most common scenario, a crossover trial involves two treatments which are consecutively administered in each patient recruited in the study. The main purpose served by the design is to provide a basis for separating treatment effects from period effects. This is achieved via computing the treatment effects separately in two sequence groups formed via randomization. The differences between treatment effects can be assessed by means of a standard t-test for independent samples using the intra-individual differences between the outcomes in both periods as the raw data. The existence of carryover effects must be ruled out for this method to be valid. This assumption is usually checked using a pre-test, which is also described in this article. Finally, we briefly discuss the use of nonparametric tests instead of t-tests and more complicated designs with more than two test periods and/or treatments. CONCLUSION: Crossover trials in which the results are not analyzed separately by sequence group are of limited, if any, scientific value. It is also essential to guard against carryover effects. Whenever ignoring such effects proves unjustified, the treatment effect must be analyzed solely via an analysis of the data obtained during the first trial period. Even the use of this restricted dataset yields results whose validity is not beyond question.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Two-Period Change-Over Design and Its Use in Clinical Trials
Grizzle, J. E. (1965) · Biometrics · doi:10.2307/2528104 · Cited by 784
Testing Statistical Hypotheses of Equivalence and Noninferiority
Wellek, S. (2010) · doi:10.1201/ebk1439808184 · Cited by 548
Self-citationDesign and Analysis of Cross-Over Trials
Jones, B., & Kenward, M. G. (2003) · Chapman & Hall/CRC eBooks · doi:10.1201/9781420036091 · Cited by 484
Koch, G. G. (1972) · Biometrics · doi:10.2307/2556170 · Cited by 465
Confidence Interval or P-Value? Part 4 of a Series on Evaluation of Scientific Publications
Prel, J.-B. D., Hommel, G., Röhrig, B., & Blettner, M. (2009) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2009.0335 · Cited by 460
Self-citationKarst, M., Salim, K., Burstein, S., Conrad, I., Hoy, L., & Schneider, U. (2003) · JAMA · doi:10.1001/jama.290.13.1757 · Cited by 340
The performance of the two‐stage analysis of two‐treatment, two‐period crossover trials
Freeman, P. R. (1989) · Statistics in Medicine · doi:10.1002/sim.4780081202 · Cited by 272
Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease
Chung, K. A., Lobb, B. M., Nutt, J. G., & Horak, F. B. (2010) · Neurology · doi:10.1212/wnl.0b013e3181f6128c · Cited by 252
Kabisch, M., Ruckes, C., Seibert‐Grafe, M., & Blettner, M. (2011) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2011.0663 · Cited by 186
Self-citationdu Prel, J.-B., Röhrig, B., Hommel, G., & Blettner, M. (2010) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2010.0343 · Cited by 161
Self-citation
Cited by
CONSORT 2010 statement: extension to randomised crossover trials
Dwan, K., Li, T., Altman, D. G., & Elbourne, D. (2019) · BMJ · doi:10.1136/bmj.l4378 · Cited by 785
Prebiotic inulin-type fructans induce specific changes in the human gut microbiota
Vandeputte, D., Falony, G., Vieira-Silva, S., Wang, J., Sailer, M., Theis, S., Verbeke, K., & Raes, J. (2017) · Gut · doi:10.1136/gutjnl-2016-313271 · Cited by 554
Air pollution and DNA methylation: effects of exposure in humans
Rider, C. F., & Carlsten, C. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0713-2 · Cited by 363
Randomized controlled trials – a matter of design
Siepmann, T., Spieth, P. M., Kubasch, A. S., Penzlin, A. I., Illigens, B. M.-W., & Barlinn, K. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s101938 · Cited by 292
Hui, F., Tang, J., Williams, P. A., McGuinness, M. B., Hadoux, X., Casson, R. J., Coote, M., Trounce, I. A., Martin, K. R., van Wijngaarden, P., et al. (2020) · Clinical & Experimental Ophthalmology · doi:10.1111/ceo.13818 · Cited by 226
Metadata
- Authors
- Wellek, S., & Blettner, M.
- Venue
- Deutsches Ärzteblatt international
- Publisher
- Deutscher Arzte-Verlag GmbH
- Published
- 2012-04-13
- Volume
- 109
- Issue
- 15
- Pages
- 276-81
- ISSN
- 1866-0452 (ISSN-L)
- OpenAlex
- W2125281699
- Cited by
- 424
- References
- 19
- FWCI
- 12.88
- Type
- journal article
- Language
- de
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: On the Proper Use of the Crossover Design in Clinical Trials. https://app.cochat.ai/papers/10.3238/arztebl.2012.0276
- The paper
- Wellek, S., & Blettner, M. (2012). On the Proper Use of the Crossover Design in Clinical Trials. Deutsches Ärzteblatt international. https://doi.org/10.3238/arztebl.2012.0276
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.